Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Por um escritor misterioso
Descrição
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
Lihu Yang's research works Merck & Co., Whitehouse Station (MSD) and other places
Immune regulation by atypical chemokine receptors
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
